Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Federal Trade Commission (FTC) has cleraed the consent order for the acquisition of Cephalon by Teva Pharmaceuticals.
Subscribe to our email newsletter
As per the consent order, Teva should divest two Abbreviated New Drug Applications (ANDAs) for fentanyl citrate lozenges and cyclobenzaprine ER capsules.
Fentanyl citrate lozenges is a generic version of Actiq and cyclobenzaprine ER capsules are the generic version of Amrix.
Teva is known for developing, producing and marketing generic drugs besides specialty pharmaceuticals